'Game Changer': Treat Diabetes and Also Reduce CV Risk

Drs Shubrook and Chamberlain discuss cardiovascular risk reduction associated with SGLT-2 inhibitors and GLP-1 agonists in T2D, and advise clinicians to ' be aware. '

Source: Medscape Medscape Podcast - February 9, 2018 Category: General Medicine Authors: Medscape Source Type: podcasts